2012 Aarkstore.com | Movement Disorders – Pipeline Review, H2 2012 by aarks222


									Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Movement Disorders – Pipeline Review, H2 2012


You can also request for sample page of above mention reports on


Global Markets Direct’s, Movement Disorders - Pipeline Review, H2 2012, provides
an overview of the Movement Disorders therapeutic pipeline. This report provides
information on the therapeutic development for Movement Disorders, complete
with latest updates, and special features on late-stage and discontinued projects. It
also reviews key players involved in the therapeutic development for Movement
Disorders. Movement Disorders - Pipeline Review, H2 2012 is built using data and
information sourced from Global Markets Direct’s proprietary databases,
Company/University websites, SEC filings, investor presentations and featured
press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.


- A snapshot of the global therapeutic scenario for Movement Disorders.
- A review of the Movement Disorders products under development by companies
and universities/research institutes based on information derived from company
and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
Table of contents:

List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Movement Disorders Overview 8
Therapeutics Development 9
An Overview of Pipeline Products for Movement Disorders 9
Movement Disorders Therapeutics under Development by Companies 11
Movement Disorders Therapeutics under Investigation by Universities/Institutes 15
Late Stage Products 17
Comparative Analysis 17
Mid Clinical Stage Products 18
Comparative Analysis 18
Early Clinical Stage Products 19
Comparative Analysis 19
Pre-Clinical Stage Products 20
Comparative Analysis 20
Movement Disorders Therapeutics – Products under Development by Companies 21
Movement Disorders Therapeutics – Products under Investigation by
Universities/Institutes 24
Companies Involved in Movement Disorders Therapeutics Development 25
Johnson & Johnson 25
Allergan, Inc. 26
Merck & Co., Inc. 27
Otsuka Pharmaceutical Co., Ltd. 28
XenoPort, Inc. 29
Ipsen S.A. 30
Neurocrine Biosciences, Inc. 31
Novartis AG 32
Cubist Pharmaceuticals, Inc. 33
Merz GmbH & Co. KGaA 34
Sun Pharmaceutical Industries Limited 35
IMPAX Laboratories, Inc. 36
Addex Pharmaceuticals 37
GW Pharmaceuticals plc 38
Medicure Inc. 39
NeuroSearch A/S 40

List of Figures

List of Tables are also include.

For more related Reports Plz follow The link:

Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2

Movement Disorders – Pipeline Review, H2 2012

Bone Metastasis – Pipeline Review, H2 2012

Cognitive Impairment – Pipeline Review, H2 2012

Mycoses – Pipeline Review, H2 2012

Skin Inflammation – Pipeline Review, H2 2012

Kidney Disease – Pipeline Review, H2 2012

Allergies – Pipeline Review, H2 2012

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) – Pipeline
Review, H2 2012

Transplantation – Pipeline Review, H2 2012
Liver Transplantation – Pipeline Review, H2 2012

Myelodysplastic Syndrome – Pipeline Review, H2 2012

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and

For More details Plz do contact :

Aarkstore Enterprise



Email: enquiry@aarkstore.com

To top